https://www.thebodypro.com/author/barbara-jungwirth
Barbara Jungwirth

Barbara Jungwirth

Barbara Jungwirth is an experienced freelance journalist, writer, and translator who has been reporting on HIV for TheBody and TheBodyPro since 2002. Specializing in technical summaries of published and presented research on HIV and related topics, Barbara has been the primary author of TheBodyPro's "This Week in HIV Research" series since 2014.

Latest by Barbara Jungwirth

Promo Image
News

This Week in HIV Research: The Unsung Opportunities of Long-Acting Antiretrovirals

March 4, 2021: Improving care for PLWH in transition from incarceration; long-acting PrEP's potential in Black and Latinx communities; comorbidity rates and COVID-19 risk among PLWH; how COVID lockdowns affect the HIV epidemic.

By Barbara Jungwirth and Myles Helfand
magnifying glass
News

This Week in HIV Research: The Importance of Challenging Our Assumptions

Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.

By Barbara Jungwirth and Myles Helfand
good sleep
News

This Week in HIV Research: To Sleep, Perchance to Dream

Feb. 18, 2021: Insomnia rates among PLWH; trends in multimorbidity diagnosis; viral load control loss in the modern HIV treatment era; acceptability of HIV self-test dissemination methods.

By Barbara Jungwirth and Myles Helfand
rapid HIV test
News

This Week in HIV Research: Early Screening Matters, and Not Just for HIV

Feb. 11, 2021: Early comorbidity development among women living with HIV; type 2 heart attack frequency; assessing European-based CVD assessment tools; long-term cognitive dysfunction and HIV/hepatitis coinfection.

By Barbara Jungwirth and Myles Helfand
parachute
News

This Week in HIV Research: What Risk Compensation?

Feb. 4, 2021: STI rates among PrEP users; how Medicaid expansion affects HIV testing and PrEP rates; utilizing mental health care providers in PrEP uptake; adapting HIV care in the COVID era.

By Barbara Jungwirth and Myles Helfand
building bridges
News

This Week in HIV Research: The Bridges We Strive to Make

Jan. 28, 2021: COVID-19 information mistrust among Black PLWH; opportunities to intervene prior to deadly drug overdoses; we're unprepared for end-of-life needs for aging PLWH; hospitalization disparities despite universal health care.

By Barbara Jungwirth and Myles Helfand
doctor patient hands
News

This Week in HIV Research: Health in Unity

Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.

By Barbara Jungwirth and Myles Helfand
rocky road
News

This Week in HIV Research: A Patient’s History Really Matters

Jan. 14, 2021: Interpersonal violence history and adverse HIV outcomes; the incidence and severity of breast cancer; the effect of menopause on integrase-associated weight gain; two-drug therapy for HIV treatment-experienced people.

By Barbara Jungwirth and Myles Helfand
healthcare dark
News

This Week in HIV Research: Delivering Care Through Uncertainty

Jan. 7, 2021: HIV status and COVID-19 disease severity; associations between tobacco smoking, cancer incidence, viral load, and CD4 count; immune recovery on integrase inhibitors; using smart pill bottles to boost adherence.

By Barbara Jungwirth and Myles Helfand
teamwork
News

This Week in HIV Research: Teamwork Makes the Dream Work

Dec. 28, 2020: The power of clinic-pharmacy collaborations; overcoming COVID-19-induced barriers to HIV care; urine testing as a PrEP adherence tool; using incarceration history in PrEP Rx assessments.

By Barbara Jungwirth and Myles Helfand